OREXIGEN THERAPEUTICS, INC.

Profile

Company Names

OREXIGEN THERAPEUTICS, INC.

Addresses

3344 N. TORREY PINES CT., SUITE 200, LA JOLLA, CA 92037

Phone Numbers

(858) 875-8600

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$274,597,000.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2017-02-23 
$49,597,000.00 
$49,597,000.00 
$0.00 
Debt 
2
2016-03-21 
$165,000,000.00 
$329,999,991.00 
$164,999,991.00 
Equity, Debt 
1
2015-09-10 
$60,000,000.00 
$90,000,000.00 
$30,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
HEATHER 
 
ACE 
EXECUTIVE OFFICER
OREXIGEN THERAPEUTICS, INC.
LOUIS 
C 
BOCK 
DIRECTOR
DIADEXUS INC   |  OREXIGEN THERAPEUTICS, INC.
THOMAS 
 
CANNELL 
EXECUTIVE OFFICER
OREXIGEN THERAPEUTICS, INC.
WENDY 
L 
DIXON 
DIRECTOR
OREXIGEN THERAPEUTICS, INC.
BRIAN 
H. 
DOVEY 
DIRECTOR
SKINMEDICA INC   |  DP VIII ASSOCIATES, L.P.   |  DOMAIN PARTNERS VIII, L.P.   |  NOVALAR PHARMACEUTICALS INC   |  FRACTYL LABORATORIES INC.   |  REVISION OPTICS INC   |  COLORESCIENCE INC   |  DOMAIN PARTNERS IX, L.P.   |  OREXIGEN THERAPEUTICS, INC.   |  MIRAMAR LABS, INC.
DAVID 
J 
ENDICOTT 
DIRECTOR
OREXIGEN THERAPEUTICS, INC.
PETER 
 
FLYNN 
EXECUTIVE OFFICER
PLUTONIC POWER CORP   |  OREXIGEN THERAPEUTICS, INC.   |  ARTIVA BIOTHERAPEUTICS, INC.
JOSEPH 
 
HAGAN 
EXECUTIVE OFFICER
WEALTHCOLONY SPV I, L.P.   |  ZOSANO PHARMA CORP   |  OREXIGEN THERAPEUTICS, INC.   |  WEALTHCOLONY SPV II, L.P.   |  REGULUS THERAPEUTICS INC.   |  AF HOLDCO, LLC
PETER 
K 
HONIG 
DIRECTOR
OREXIGEN THERAPEUTICS, INC.
DEBORAH 
 
JORN 
DIRECTOR
OREXIGEN THERAPEUTICS, INC.
JASON 
 
KEYES 
EXECUTIVE OFFICER
OREXIGEN THERAPEUTICS, INC.   |  ACTUATE THERAPEUTICS, INC.
PRESTON 
 
KLASSEN 
EXECUTIVE OFFICER
OREXIGEN THERAPEUTICS, INC.   |  CHINOOK THERAPEUTICS U.S., INC.
THOMAS 
 
LYNCH 
EXECUTIVE OFFICER
PROFECTUS BIOSCIENCES INC   |  XOS TECHNOLOGIES INC   |  EVOFEM HOLDINGS, INC.   |  OREXIGEN THERAPEUTICS, INC.   |  MRMMK HOLD CO.   |  IPI DATA CENTER PARTNERS FUND I-A, L.P.   |  IPI DATA CENTER PARTNERS FUND I-B, L.P.   |  EVOFEM BIOSCIENCES, INC.   |  EVOFEM BIOSCIENCES, INC.   |  FUSION RECRUITING LABS, INC.   |  IPI PARTNERS II-A, L.P.   |  IPI PARTNERS II-B, L.P.   |  IPI PARTNERS II-D, L.P.   |  STACK INFRASTRUCTURE USA II, LLC   |  STACK PARCEL HOLDINGS, LLC   |  BAINBRIDGE HEALTH, INC.   |  IPI PARTNERS III-B, L.P.   |  IPI PARTNERS III-A, L.P.   |  QVIDTVM INC.   |  STACK NVA HOLDINGS REIT, LLC   |  AQ SUNSHINE PARENT, LLC
PATRICK 
J 
MAHAFFY 
DIRECTOR
OREXIGEN THERAPEUTICS, INC.
MICHAEL 
 
NARACHI 
EXECUTIVE OFFICER, DIRECTOR
CELLADON CORP   |  OREXIGEN THERAPEUTICS, INC.
ECKARD 
 
WEBER 
DIRECTOR
SEQUEL PHARMACEUTICALS INC   |  TOBIRA THERAPEUTICS, INC.   |  ASCENTA THERAPEUTICS, INC.   |  ADYNXX INC   |  TRAGARA PHARMACEUTICALS, INC.   |  OCERA THERAPEUTICS, INC.   |  SANTA MARIA BIOTHERAPEUTICS, INC.   |  PINTA BIOTHERAPEUTICS, INC.   |  NINA BIOTHERAPEUTICS, INC.   |  OREXIGEN THERAPEUTICS, INC.   |  ADYNXX, INC.   |  ADASTRA PHARMACEUTICALS, INC.
LOTA 
S 
ZOTH 
DIRECTOR
OREXIGEN THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-03-03
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2017-02-23 
2016-03-29
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-03-21 
2015-09-15
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-09-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
LEERINK PARTNERS LLC
39011
LEERINK PARTNERS LLC
39011